Work

Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy

Year: 2011

Type: article

Source: Oncogene

DOI: 10.1038/onc.2011.267

Authors: S Spiegel, S Milstien, S Grant

Institutions: Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center, Virginia Commonwealth University Medical Center

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases

Awards: G1097778143, G131572022, G1353051725, G146968441, G201308226, Intracellular Functions of the Bioactive Sphingolipid Metabolites Sphingosine and Sphingosine-1-phosphate, G225834018, G3148123924, G319832632, G3518617075, G354229063, Cellular & Inflammatory Pathways in Ashtma & Allergic Diseases: From IgE to Cells, G471379343, Sphingosine kinases in cancer cell signaling, G5240870613, G884243897, Phase I Trial of Bortezomib and Romidepsin in CLL and Small Cell Lymphoma

OpenAlex ID: W2072116000

FWCI: 7.051

Cites: 123

Cited by: 141

Related to: 10